Ilan Shiloah - 15 Aug 2024 Form 3 Insider Report for Biomotion Sciences (SLXN)

Reporting relationship
Director
Issuer ticker
SLXN
Reported as of
15 Aug 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
15 Aug 2024, 19:47:32 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mirit Horenshtein- Hadar, as attorney for Ilan Shiloah

Key filing fact

Ilan Shiloah filed Form 3 for Biomotion Sciences (SLXN) on 15 Aug 2024.

Key facts

  • This page summarizes Ilan Shiloah's Form 3 filing for Biomotion Sciences (SLXN).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Aug 2024, 19:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLXN holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
387,883
Date
15 Aug 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLXN holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Aug 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
19,914
Exercise price
$4.17
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options have vested and are exercisable as of the date hereof.

SEC remarks

Exhibit 24.1 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .